Lupartumab, CAS 1640971-88-5

Product Description: Lupartumab (BAY 1112623) is an anti-LYPD3 (C4.4A) monoclonal antibody that can be used for the synthesis of antibody-drug conjugate BAY 1129980[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Willuda J, et al. Preclinical Antitumor Efficacy of BAY 1129980-a Novel Auristatin-Based Anti-C4.4A (LYPD3) Antibody-Drug Conjugate for the Treatment of Non-Small Cell Lung Cancer. Mol Cancer Ther. 2017 May;16(5):893-904.

CAS Number: 1640971-88-5

Molecular Weight: N/A

Compound Purity: 99.32

Research Area: Cancer

Solubility: H2O

Target: ADC Antibody

• SKU: MEXHY-P99718-1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99718-1
• Package Unit: 1 mg
• Quantity Unit: STK
• Conjugate: Unconjugated